SCHEMBL2397429

SCHEMBL2397429

O=P(O)(O)Cc1cnc2ccccc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 1/20 0.48
MGAM O43451 1/20 0.47
HDAC6 Q9UBN7 1/20 0.46
RAB9A P51151 5/20 0.46
NPC1 O15118 3/20 0.46
MAPT P10636 1/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TRPV1 Q8NER1 2/20 0.45
CYP1A2 P05177 2/20 0.44
ALDH1A1 P00352 2/20 0.44
CFTR P13569 1/20 0.44
PDGFRB P09619 1/20 0.44
PDGFRA P16234 1/20 0.44
KDM4E B2RXH2 2/20 0.43
LMNA P02545 1/20 0.43
POLB P06746 1/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21171726 0.80 TRPV1 (0.51) KDRMGAMHDAC6RAB9ATRPV1
SCHEMBL2401749 0.77 NPY5R (0.46) RAB9ATRPV1CYP1A2LMNAPOLB
SCHEMBL21171720 0.77 HDAC6 (0.49) HDAC6CYP1A2
SCHEMBL21171892 0.77 S1PR3 (0.43) KDRMGAMHDAC6RAB9ANPC1
SCHEMBL21171709 0.77 SMN1; SMN2 (0.41) KDRMGAMHDAC6RAB9ANPC1
SCHEMBL30831434 0.77 ALDH1A1 (0.53) MGAMRAB9ANPC1MAPTSMN1; SMN2
SCHEMBL701411 0.77 ALDH1A1 (0.53) MGAMRAB9ANPC1MAPTSMN1; SMN2
SCHEMBL263918 0.77 CYP1A2 (0.52) MGAMRAB9AMAPTCYP1A2ALDH1A1
SCHEMBL6597946 0.77 CYP1A2 (0.52) MGAMRAB9AMAPTSMN1; SMN2CYP1A2
SCHEMBL30101236 0.77 CYP1A2 (0.52) MGAMRAB9AMAPTCYP1A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2066627-B1 NOVEL MINOR GROOVE BINDERS UNIV STRATHCLYDE (GB) 2013-10-23 EP disclosed
US-20130065857-A1 NOVEL DXR INHIBITORS FOR ANTIMICROBIAL THERAPY BAYLOR COLLEGE OF MEDICINE (US) 2013-03-14 US disclosed
US-20130065857-A1 NOVEL DXR INHIBITORS FOR ANTIMICROBIAL THERAPY BAYLOR COLLEGE OF MEDICINE (US) 2013-03-14 US disclosed
US-8012967-B2 Minor groove binders UNIVERSITY OF STRATHCLYDE (GB) 2011-09-06 US disclosed
US-20100016311-A1 NOVEL MINOR GROOVE BINDERS UNIVERSITY OF STRATHCLYDE (GB) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016311-A1 NOVEL MINOR GROOVE BINDERS TOP2B, DNA2, CTCF KDR 2030/4885MGAM 3274/4885HDAC6 334/4885
US-20130065857-A1 NOVEL DXR INHIBITORS FOR ANTIMICROBIAL THERAPY DDX18, FPR1, DCXR KDR 4554/4885MGAM 3227/4885HDAC6 3219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.